Hsiu Yueh Lin
Investor Relations Contact at CENTER LABORATORIES, INC.
Profile
Hsiu Yueh Lin is currently a Director at Univision Pharmaceutical Co., Ltd., Head-Management at Center Laboratories, Inc. (since 1998), and a Member-Supervisory Board at Anhui Jinlac.
Biotech Ltd.
She was previously a Director at TPG Biologics, Inc. and a Member-Supervisory Board at glac Biotech Co., Ltd.
Ms. Lin received an undergraduate degree from National Cheng Kung University.
Hsiu Yueh Lin active positions
| Companies | Position | Start |
|---|---|---|
| CENTER LABORATORIES, INC. | Investor Relations Contact | - |
| Univision Pharmaceutical Co., Ltd. | Director/Board Member | - |
| Anhui Jinlac Biotech Ltd. | Director/Board Member | - |
Former positions of Hsiu Yueh Lin
| Companies | Position | End |
|---|---|---|
| TPG BIOLOGICS INC | Director/Board Member | - |
| GLAC BIOTECH CO., LTD. | Director/Board Member | - |
Training of Hsiu Yueh Lin
| National Cheng Kung University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CENTER LABORATORIES, INC. | Health Technology |
| Private companies | 4 |
|---|---|
| Univision Pharmaceutical Co., Ltd. | |
glac Biotech Co., Ltd.
 glac Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology glac Biotech Co., Ltd. engages in the production, research, development, and sales of probiotics. It offers probiotics in the application of healthcare, food, and agriculture. The company's products include functional probiotic powders and fermented products such as yogurt and yogurt ice cream. glac Biotech was founded on July 30, 2008 and is headquartered in Tainan, Taiwan. | Health Technology |
TPG Biologics, Inc.
 TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |
| Anhui Jinlac Biotech Ltd. |
- Stock Market
- Insiders
- Hsiu Yueh Lin